منابع مشابه
Recent advances in management of renal cancer
Therapeutic options for patients with metastatic renal cell carcinoma have significantly improved over the past few years, resulting in prolonged progression-free and overall survival.
متن کاملCurrent Management Options in Metastatic Renal Cell Cancer
Renal cancer accounts for 2.4% of all cancers. Localised disease accounts for the majority of renal cancers (70-75%), however 20-25% of these ultimately develop distant metastasis. The median overall survival of un treated metastatic disease is 5 months with 1-year survival of only 29%. The management of metastatic renal cell cancers traditionally relied on systemic immunotherapy with attendant...
متن کاملRenal cancer management in a patient with chronic kidney disease.
A CT scan revealed bilateral renal masses. On the right side, a mass was discovered in the lateral cortex of the mid kidney that measured approximately 2.7 × 1.8 cm in the cross-section and 3.2 cm in length; it appeared to be solid and heterogeneously enhanced (Figure). On the left side, a focal lesion in the lateral cortex of the mid kidney, measuring approximately 2.2 × 1.5 cm in the maximal ...
متن کاملFamilial Renal Cancer: Molecular Genetics and Surgical Management
Familial renal cancer (FRC) is a heterogeneous disorder comprised of a variety of subtypes. Each subtype is known to have unique histologic features, genetic alterations, and response to therapy. Through the study of families affected by hereditary forms of kidney cancer, insights into the genetic basis of this disease have been identified. This has resulted in the elucidation of a number of ki...
متن کاملCancer management in patients with end-stage renal disease.
Significant improvements in the management of patients with end-stage renal disease (ESRD) who are on chronic renal replacement therapy (CRRT), has led to an increase prevalence of this population among older Americans. Since cancer is also common in the elderly, oncologists are likely to be faced with patients who suffer from both cancer and ESRD. There is a paucity of information regarding is...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Pharmaceutical Journal
سال: 2022
ISSN: ['2053-6186', '0031-6873']
DOI: https://doi.org/10.1211/pj.2022.1.147213